If you're on the lookout for a passive income boost, then you may want to check out the ASX dividend stocks listed below.
Analysts have named these dividend stocks as buys and tipped them to provide very large yields in the near term. Here's what you need to know:
Image source: Getty Images
Harvey Norman Holdings Limited (ASX: HVN)
Harvey Norman could be an ASX dividend stock to buy according to analysts at Goldman Sachs.
The broker remains positive on the retailer due to its belief that it is in a strong position to fight off online competition. This is due to its exposure to regional markets and its older customer base.
Goldman highlights that "Harvey Norman holds a unique position within the electronics and appliances retail industry as a result of its franchise model of operations in Australia, property portfolio and regional exposure."
Its analysts are expecting this to allow Harvey Norman to pay fully franked dividends per share of 36 cents in FY 2023, then 30 cents in FY 2024, before a return to 36 cents in FY 2025. Based on the current Harvey Norman share price of $3.66, this will mean massive yields of 9.8%, 8.2%, and 9.8%, respectively.
Goldman has a buy rating and $4.70 price target on its shares.
Healthco Healthcare and Wellness REIT (ASX: HCW)
Another ASX dividend stock that could be a buy for income investors is the Healthco Healthcare and Wellness REIT.
This real estate investment trust invests in properties such as hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness properties. These are all relatively defensive assets and should be in demand whatever is happening in the economy.
Morgans is a fan of the company and believes it is well-placed to increase its dividend. It is forecasting dividends per share of 7.5 cents in FY 2023 and 7.8 cents FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.35, this will mean yields of 5.5% and 5.8%, respectively.
Morgans also sees plenty of upside for its shares. It has an add rating and $2.06 price target on them.
